本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Milestone Pharmaceuticals Inc.

0.9711
-0.0090-0.92%
成交量:56.37萬
成交額:54.99萬
市值:1.20億
市盈率:-1.44
高:1.04
開:0.9920
低:0.9461
收:0.9801
52周最高:3.06
52周最低:0.9461
股本:1.24億
流通股本:1.06億
量比:2.51
換手率:0.53%
股息:- -
股息率:- -
每股收益(TTM):-0.6748
每股收益(LYR):-0.7517
淨資產收益率:-35522.62%
總資產收益率:-42.78%
市淨率:6.61
市盈率(LYR):-1.29

資料載入中...

2023/03/10

重要事件披露

8-K - Current report
2023/03/07

重要事件披露

8-K - Current report
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/18

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/06

重要事件披露

8-K - Current report
2022/11/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/10

重要事件披露

8-K - Current report
2022/10/31

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/10/24

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/10/17

重要事件披露

8-K - Current report
2022/09/26

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/20

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/08/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/10

重要事件披露

8-K - Current report
2022/07/08

重要事件披露

8-K - Current report
2022/05/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]